Safety and efficacy of intradiscal nucleus pulposus allograft versus sham for lumbar discogenic pain associated with degenerative disc disease: study protocol for a randomized clinical trial
Timothy R. Deer, Pierce D. Nunley, Ramana K. Naidu, Douglas P. Beall, Timothy T. Davis, Aaron K. Calodney, Amol Soin, Morgan P. Lorio, Jon E. Block · 2026
Read Safety and efficacy of intradiscal nucleus pulposus allograft versus sham for lumbar discogenic pain associated with degenerative disc disease: study protocol for a randomized clinical trial by Timothy R. Deer, Pierce D. Nunley, Ramana K. Naidu, Douglas P. Beall, Timothy T. Davis, Aaron K. Calodney, Amol Soin, Morgan P. Lorio, Jon E. Block (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13471482.txt.
Description
Deer and co-authors present the protocol for a randomized trial of an injectable disc supplement for chronic low-back pain from worn spinal discs. Their 2026 study plan enrolls adults aged 22 to 85 with MRI-confirmed degenerative disc disease, at least six months of back pain, and disability that conservative care failed to fix.
Participants are randomized in a 2:1 ratio to one injection of nucleus pulposus allograft, donor tissue meant to refill the disc's soft core, or to a sham procedure. Neither patients nor assessors are told which. The main test is whether at least 30% pain reduction at 12 months occurs more often with active treatment. Sham patients still symptomatic at one year may cross over to the real injection.
Catalog record
| CREATOR | Timothy R. Deer, Pierce D. Nunley, Ramana K. Naidu, Douglas P. Beall, Timothy T. Davis, Aaron K. Calodney, Amol Soin, Morgan P. Lorio, Jon E. Block |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 93 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |